The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
139 jobs Number of planned job losses
Announcement Date
17 November 2009
Employment effect (start)
30 November 2009
Foreseen end date
31 December 2009
Description
After an extraordinary work council, UCB, a biopharmaceutical company, announced a restructuring plan including 174 dismissals at its site of Braine-l'Alleud. The R&D department is the most affected: 122 jobs are threatened. In September 2008, an earlier restructuring plan had been implemented leading to 300 job losses. The number of job losses was reduced to 139 in the second official notification of redundancies.
Sources
18 November 2009: Le Soir
18 November 2009: L'Echo
Citation
Eurofound (2009), UCB, Internal restructuring in Belgium, factsheet number 69903, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69903.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
